 |
 |
|
|
|
| Letrozole |
 |
| FORMULAR:C17H11N5 |
 |
| 112809-51-5 |
 |
| Letrozole is an oral, anti-estrogen drug that is used for treating postmenopausal women with breast cancer. The growth of some breast cancers in postmenopausal women is promoted by estrogens that circulate in the blood, and the adrenal glands are the main source of these circulating estrogens. Letrozole inhibits the enzyme in the adrenal glands (aromatase) that produces the estrogens, estradiol and estrone. Letrozole was approved by the FDA in 1997. |
 |
Appearance: almost white powder
Standard Conforms USP(United States of America Pharmacopeia), EP(European Pharmacopeia |
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
